NASDAQ:TGTX

Tg Therapeutics Stock Predictions

etoro logo Buy TGTX
*Your capital is at risk
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TGTX Prediction Chart

TGTX Predictions History

Latest community submissions for TGTX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Aug 11, 2023 $9.95 +2.58% $10.13 V 98.22% 1
Aug 11, 2023 $10.28 +6.01% $10.13 V 98.49% 1
Aug 11, 2023 $10.06 +3.76% $10.13 V 99.35% 4
Aug 10, 2023 $10.30 +6.39% $9.70 V 93.83% 1
Aug 10, 2023 $10.07 +3.99% $9.70 V 96.22% 1
Aug 10, 2023 $9.97 +3.32% $9.70 V 97.22% 1
Aug 7, 2023 $11.43 +6.69% $10.10 X 86.86% 0
Aug 7, 2023 $11.16 +4.18% $10.10 X 89.52% 0
Aug 7, 2023 Bullish $10.10 X 0
Jul 21, 2023 $21.57 +2.97% $20.62 X 95.38% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TGTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TG THERAPEUTICS
TG Therapeutics
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE